Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can donor t cells beat a tough virus after transplant? new trial aims to find out.

NCT ID NCT03378102

Recruiting now Disease control Sponsor: Mari Dallas Source: ClinicalTrials.gov ↗

First seen Jun 06, 2026 · Last updated Jun 13, 2026 · Updated 1 time

Summary

This early-stage study tests whether infusing virus-fighting T cells from a donor can help stem cell transplant patients overcome a stubborn adenovirus infection. About 20 participants will receive the experimental cell therapy, and researchers will monitor side effects and whether the virus clears. The goal is to see if this approach is safe and feasible.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospitals, Seidman Cancer Center, Case Comprehensive Cancer Center

    RECRUITING

    Cleveland, Ohio, 44106, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

REFRACTORY OPPORTUNISTIC ADENOVIRUS INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION